◼ Archived
Business
🔮 Archynetys predicts: fades by tomorrow — graded ✓ correct
AbbVie inks $10.9B Apogee buyout to bag eczema prospect
4sources
4articles
2velocity
+0%since first seen
22d agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (4)
- AbbVie seals $10.9B deal to acquire Waltham biotech Apogee Therapeutics The Business Journals · 23d ago
- AbbVie said to be reeling in Apogee and its Dupixent rival for almost $11B: report FirstWord Pharma · 23d ago
- Wells Fargo Maintains Overweight on AbbVie (ABBV), Sees Value in Apogee Acquisition Insider Monkey · 23d ago
- Why AbbVie Stock Jumped Today The Globe and Mail · 23d ago
Related trends
▲ Peaking
Business
Realta Fusion will develop former Oscar Mayer site in Madison, add 600 jobs
U.S. startup Realta Fusion is transforming the former Oscar Mayer plant in Madison into a fusion energy hub.
▲ Peaking
Business
Russian hackers exploiting vulnerable internet routers, NSA warns
▲ Peaking
Business
BYD says demand is ‘booming’ for the new Denza Z EV as global pre-orders top 1,000
BYD reports booming global demand for the Denza Z EV, with pre-orders exceeding 1,000 units.
▲ Peaking
Business
Report: How an email mistake derailed talks between Apple and OpenAI ahead of the lawsuit
▲ Peaking
Business
FCC Moves to End Cap on National Broadcast Ownership
The FCC is moving to repeal the 39% national ownership cap, potentially opening the door for larger TV station mergers.
▲ Peaking
Business